SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-007784
Filing Date
2021-02-04
Accepted
2021-02-04 17:02:44
Documents
2
Period of Report
2021-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1618
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4521
  Complete submission text file 0001209191-21-007784.txt   7615
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOZYME PHARMA, INC. 321 SUMMER STREET, SUITE 400 BOSTON MA 02210
Business Address
Wenkert Deborah (Reporting) CIK: 0001843346 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39397 | Film No.: 21592024